Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 2 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 13 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
13 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
SOLBOSCH EYE CLINIC from Elsene, company number BE1009375763, closed financial year 2025 with a result of € -369,126 after tax. For that financial year SOLBOSCH EYE CLINIC recorded a gross margin of € -169,974 and equity of € -351,086. Compared with financial year 2024, the result moved from € -31,961 to € -369,126. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.
€ -351,086
▼ € 369,126 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -369,126
▼ 1055 % more loss than in 2024
Profit after tax over the fiscal year.
€ 60,618
▲ 148% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -401,086.
People and assets in 2025
€ 11,853
▲ € 11,760 vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 16,171
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1.5 million
▲ 44% vs 2024
€ 64,211 is repaid this year. At this pace the long-term loan is gone in ≈ 24 years.
€ 508,669
▲ 105% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 9,719
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € -19,255 | € -169,974 | ▼ € 150,719 |
| Profit after taxes | € -31,961 | € -369,126 | ▼ € 337,165 |
| Equity | € 18,039 | € -351,086 | ▼ € 369,126 |
| Total debts | € 1,323,796 | € 2,426,263 | ▲ 83% |
| Cash | € 24,422 | € 60,618 | ▲ 148% |
| Retained profit | € -31,961 | € -401,086 | ▼ € 369,126 |
| Bank debt | € 1,050,000 | € 1,513,289 | ▲ 44% |
| Balance sheet total | € 1,341,835 | € 2,075,177 | ▲ 55% |
Key figures of SOLBOSCH EYE CLINIC, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to SOLBOSCH EYE CLINIC?
What happened at SOLBOSCH EYE CLINIC in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 369,126. Source: NBB ↗
- Ophta Salik became a director. NBB
- MorelleDoc became a director. NBB
- New establishment in Elsene. KBO
- Michez Ophtalmologie became a director. NBB
- B.G. Ophtalmo became a director. NBB
- Ophtalmus became a director. NBB
- Ophta-Surgery became a director. NBB
In short
From € 31,961 loss in 2024 to € 369,126 loss in 2025.
A new publication or filing at SOLBOSCH EYE CLINIC? We notify you, reason included.
Follow SOLBOSCH EYE CLINICDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of OPHTALMUS, Michez Ophtalmologie, DOCTEURS DEWISPELAERE ET DEBAUGNIES, MorelleDoc comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
SOLBOSCH EYE CLINICBehind SOLBOSCH EYE CLINIC are Michez Ophtalmologie, B.G. Ophtalmo, Ophtalmus, Ophta-Surgery, Ophta Salik and Centre d'Ophtalmologie Grand Angle. The shares are held by OPHTALMUS (10%), Michez Ophtalmologie (10%), DOCTEURS DEWISPELAERE ET DEBAUGNIES (10%) and MorelleDoc.
Directors
According to the 2025 annual accounts
Director
since 2024
Director
since 2024
Director
since 2024
Director
since 2024
Director
since 2025
Centre d'Ophtalmologie Grand Angle
Director
since 2024
Director
since 2024
since 2024
Director
since 2024
Director
since 2025
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Adolphe Buyllaan 110
1050 Elsene
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 13 companies are registered at this address.
All companies at this address →IMMOBILIERE CENTRE MEDICAL DU SOLBOSCH
€ 111,977 gross margin · 2025
immobiliere du solboch
€ 483,505 gross margin · 2025
Centre médical du Solbosch
ISODYN
€ 37,331 gross margin · 2025
VINCENT MUSTIN, ORL
€ 227,897 gross margin · 2025
+8 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1009.375.763
- VAT number
- BE 1009.375.763
- Registered office
- Adolphe Buyllaan 110, 1050 Elsene
- Names & denominations
- SOLBOSCH EYE CLINIC
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 15 May 2024
- Peppol
- Active · Active since 22 Jun 2024
- Activities · NACE
Activiteiten van medisch specialisten